Clinical Features and Overall Survival of Females with Hepatocellular Carcinoma: A Retrospective Study and Review of the Literature in the Association of Southeast Asian Nations

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Villanueva A, Longo DL. Hepatocellular carcinoma. N Engl J Med. 2019;380(15):1450–1462. doi:10.1056/NEJMra1713263
   PubMed Web of Science ®Google Scholar
• Jack Wands MD. Hepatocellular carcinoma and sex. N Engl J Med. 2007;357:1974–1976. doi:10.1056/NEJMcibr075652
   Web of Science ®Google Scholar
• El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132(7):2557–2576. doi:10.1053/j.gastro.2007.04.061
   PubMed Web of Science ®Google Scholar
• Chonprasertsuk S, Vilaichone RK. Epidemiology and treatment of hepatocellular carcinoma in Thailand. Jpn J Clin Oncol. 2017;47(4):294–297. doi:10.1093/jjco/hyw197
   PubMed Web of Science ®Google Scholar
• Schutte K, Bornschein J, Malfertheiner P. Hepatocellular carcinoma--epidemiological trends and risk factors. Dig Dis. 2009;27(2):80–92. doi:10.1159/000218339
   PubMed Web of Science ®Google Scholar
• Ladenheim MR, Kim NG, Nguyen P, et al. Sex differences in disease presentation, treatment and clinical outcomes of patients with hepatocellular carcinoma: a single-centre cohort study. BMJ Open Gastroenterol. 2016;3(1):e000107. doi:10.1136/bmjgast-2016-000107
   Google Scholar
• Farinati F, Sergio A, Giacomin A, et al. Is female sex a significant favorable prognostic factor in hepatocellular carcinoma? Eur J Gastroenterol Hepatol. 2009;21(10):1212–1218. doi:10.1097/MEG.0b013e32831a86f8
   Web of Science ®Google Scholar
• Kazufumi Dohmen HS, Irie K, Shibashi H, Ishibashi H. Longer survival in female than male with hepatocellular carcinoma. J Gastroenterol Hepatol. 2003;18:267–272. doi:10.1046/j.1440-1746.2003.02936.x
   Web of Science ®Google Scholar
• Guo H, Wu T, Lu Q, et al. Hepatocellular carcinoma in elderly: clinical characteristics, treatments and outcomes compared with younger adults. PLoS One. 2017;12(9):e0184160. doi:10.1371/journal.pone.0184160
   PubMed Web of Science ®Google Scholar
• Borzio M, Dionigi E, Vitale A, et al. Management and prognosis of hepatocellular carcinoma in the elderly: results of an in-field multicenter cohort study. Liver Int. 2017;37(8):1184–1192. doi:10.1111/liv.13392
   PubMed Web of Science ®Google Scholar
• Tangkijvanich P, Mahachai V, Suwangool P, Poovorawan Y. Gender difference in clinicopathologic features and survival of patients with hepatocellular carcinoma. World J Gastroenterol. 2004;10(11):1547–1550. doi:10.3748/wjg.v10.i11.1547
   Web of Science ®Google Scholar
• Tsukioka G, Kakizaki S, Sohara N, et al. Hepatocellular carcinoma in extremely elderly patients: an analysis of clinical characteristics, prognosis and patient survival. World J Gastroenterol. 2006;12(1):48–53. doi:10.3748/wjg.v12.i1.48
   Web of Science ®Google Scholar
• Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723–750. doi:10.1002/hep.29913
   PubMed Web of Science ®Google Scholar
• Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127(5 Suppl 1):S35–50. doi:10.1053/j.gastro.2004.09.014
   PubMed Web of Science ®Google Scholar
• Zhu RX, Seto WK, Lai CL, Yuen MF. Epidemiology of hepatocellular carcinoma in the Asia-Pacific region. Gut Liver. 2016;10(3):332–339. doi:10.5009/gnl15257
   PubMed Web of Science ®Google Scholar
• de Martel C, Maucort-Boulch D, Plummer M, Franceschi S. World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology. 2015;62(4):1190–1200. doi:10.1002/hep.27969
   PubMed Web of Science ®Google Scholar
• Phipps M, Livanos A, Guo A, et al. Gender matters: characteristics of hepatocellular carcinoma in women from a large, multicenter study in the United States. Am J Gastroenterol. 2020;115:1486–1495. doi:10.14309/ajg.0000000000000643
   Web of Science ®Google Scholar
• Somboon K, Siramolpiwat S, Vilaichone RK. Epidemiology and survival of hepatocellular carcinoma in the central region of Thailand. Asian Pac J Cancer Prev. 2014;15(8):3567–3570. doi:10.7314/apjcp.2014.15.8.3567
   Google Scholar
• Chitapanarux T, Phornphutkul K. Risk factors for the development of hepatocellular carcinoma in Thailand. J Clin Transl Hepatol. 2015;3(3):182–188. doi:10.14218/JCTH.2015.00025
   Google Scholar
• Garcia Comas L, Ordobas Gavin M, Sanz Moreno JC, et al. Prevalence of hepatitis C antibodies in the population aged 16–80 years in the community of Madrid 2008–2009. J Med Virol. 2015;87(10):1697–1701. doi:10.1002/jmv.24219
   Web of Science ®Google Scholar
• Wasitthankasem R, Posuwan N, Vichaiwattana P, et al. Decreasing hepatitis C virus infection in Thailand in the past decade: evidence from the 2014 National Survey. PLoS One. 2016;11(2):e0149362. doi:10.1371/journal.pone.0149362
   Web of Science ®Google Scholar
• Singal AG, Pillai A, Tiro J, Klenerman P. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med. 2014;11(4):e1001624. doi:10.1371/journal.pmed.1001624
   PubMed Web of Science ®Google Scholar
• Bialecki ESBA, Di Bisceglie AM. Clinical presentation and natural course of hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2005;17:485–489. doi:10.1097/00042737-200505000-00003
   PubMed Web of Science ®Google Scholar
• Hassan MM, Spitz MR, Thomas MB, et al. The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States. J Hepatol. 2009;50(2):334–341. doi:10.1016/j.jhep.2008.08.016
   Web of Science ®Google Scholar
• Carr BI, Guerra V. Serum albumin levels in relation to tumor parameters in hepatocellular carcinoma patients. Int J Biol Markers. 2017;32(4):e391–e396. doi:10.5301/ijbm.5000300
   PubMed Web of Science ®Google Scholar
• Li MX, Bi XY, Li ZY, et al. Prognostic role of Glasgow Prognostic Score in patients with hepatocellular carcinoma: a systematic review and meta-analysis. Medicine (Baltimore). 2015;94(49):e2133. doi:10.1097/MD.0000000000002133
   PubMed Web of Science ®Google Scholar
• Hussain SP, Schwank J, Staib F, Wang XW, Harris CC. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene. 2007;26(15):2166–2176. doi:10.1038/sj.onc.1210279
   PubMed Web of Science ®Google Scholar
• Zhan P, Ji YN, Yu LK. TP53 mutation is associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a meta-analysis. Hepatobiliary Surg Nutr. 2013;2(5):260–265. doi:10.3978/j.issn.2304-3881.2013.07.06
   Google Scholar
• Wanich N, Vilaichone RK, Chotivitayatarakorn P, Siramolpiwat S. High prevalence of hepatocellular carcinoma in patients with chronic hepatitis B infection in Thailand. Asian Pac J Cancer Prev. 2016;17(6):2857–2860.
   Google Scholar
• Le VQ, Nguyen VH, Nguyen VH, et al. Epidemiological characteristics of advanced hepatocellular carcinoma in the northern region of Vietnam. Cancer Control. 2019;26(1):1073274819862793. doi:10.1177/1073274819862793
   Web of Science ®Google Scholar
• Goh GB, Li JW, Chang PE, Chow KY, Tan CK. Deciphering the epidemiology of hepatocellular carcinoma through the passage of time: a study of 1401 patients across 3 decades. Hepatol Commun. 2017;1(6):564–571. doi:10.1002/hep4.1059
   Web of Science ®Google Scholar
• Norsa’adah B, Nurhazalini-Zayani CG. Epidemiology and survival of hepatocellular carcinoma in north-east Peninsular Malaysia. Asian Pac J Cancer Prev. 2013;14(11):6955–6959. doi:10.7314/apjcp.2013.14.11.6955
   Google Scholar